V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007423 | 310004567 | 1.7 | 72.1 | Curative (C) | null | 2016-09-06 | ESHAP | null | null | 310018130 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007424 | 310007936 | 1.62 | 50 | Palliative (P) | 2016-10-17 | 2016-10-29 | Ipilimumab | 02 | N | 310018132 | IPILIMUMAB |
| 310007425 | 310007936 | 1.7 | null | null | 2018-03-12 | 2018-04-03 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 2 | N | 310018132 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007426 | 310007936 | 1.77 | 39 | null | 2018-01-01 | 2018-01-16 | Cyclophosphamide High Dose | 02 | N | 310018132 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007427 | 310004568 | 1.8 | 79.5 | Curative (C) | 2019-02-13 | 2019-02-15 | Cisplatin + Radiotherapy | N | N | 310018147 | CISPLATIN + RT |
| 310007428 | 310004569 | 1.56 | null | Adjuvant (A) | 2012-12-08 | 2013-04-20 | Docetaxel 75mg/m2 (21 day) | Y | N | 310018151 | DOCETAXEL |
| 310007429 | 310004569 | 1.69 | 91.7 | Not known (9) | 2014-03-12 | 2014-07-26 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 310018151 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007430 | 310004571 | 1.74 | 75.3 | Adjuvant (A) | 2015-12-31 | 2014-05-27 | CISPLATIN + RT | N | N | 310018162 | CISPLATIN + RT |
| 310007434 | 310004574 | 1.6 | 63 | Palliative (P) | 2015-11-14 | 2015-11-21 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | N | 310018189 | CARBOPLATIN + ETOPOSIDE |
| 310007435 | 310004574 | 1.82 | 32.8 | null | 2017-09-22 | 2017-09-22 | Docetaxel | N | N | 310018189 | DOCETAXEL |
| 310007436 | 310004576 | 1.55 | null | Curative (C) | 2018-01-18 | 2018-01-21 | GDP | N | N | 310018199 | GDP |
| 310007437 | 310004577 | null | 96.5 | Curative (C) | 2017-07-18 | 2017-07-23 | Rituximab | N | N | 310018203 | RITUXIMAB |
| 310007438 | 310004577 | 1.81 | 78.8 | Disease modification (D) | 2013-11-05 | 2014-09-10 | CYCLOPHOSPHAMIDE | 2 | N | 310018203 | CYCLOPHOSPHAMIDE |
| 310007439 | 310004578 | null | 91.5 | Neo-adjuvant (N) | 2015-02-13 | 2015-02-14 | ETOPOSIDE | N | N | 310018216 | ETOPOSIDE |
| 310007440 | 310004579 | 1.69 | 67 | Curative (C) | 2013-09-21 | 2013-09-21 | Bexarotene | N | null | 310018228 | BEXAROTENE |
| 310007441 | 310004580 | 1.85 | 77 | Curative (C) | 2017-10-19 | 2017-12-07 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | null | 310018236 | DOCETAXEL + GEMCITABINE |
| 310007442 | 310009739 | null | null | Curative (C) | 2015-09-14 | 2015-09-14 | ETOPOSIDE | N | Y | 310018244 | ETOPOSIDE |
| 310007443 | 310010699 | 1.74 | null | Palliative (P) | 2018-07-07 | 2018-07-30 | GDP | Y | null | 310018245 | GDP |
| 310007444 | 310004584 | 1.72 | 75.7 | Curative (C) | 2017-12-28 | 2017-12-28 | GDP | N | null | 310018259 | GDP |
| 310007445 | 310004584 | null | 52.3 | Palliative (P) | 2016-07-10 | 2016-08-31 | Carboplatin + Etoposide IV 3 day | 02 | N | 310018259 | UKALL2011 |
| 310007446 | 310004584 | 1.78 | 78.6 | null | 2016-11-03 | 2017-03-23 | Etoposide oral | N | N | 310018259 | ETOPOSIDE |
| 310007447 | 310004585 | null | 68 | Palliative (P) | 2015-03-10 | 2015-03-15 | Ipilimumab | 02 | Y | 310018266 | IPILIMUMAB |
| 310007448 | 310004585 | 1.56 | 79 | Palliative (P) | 2013-11-22 | 2013-12-31 | Ipilimumab | N | null | 310018266 | IPILIMUMAB |
| 310007449 | 310004586 | 1.71 | 53.5 | Curative (C) | null | 2015-10-24 | Cisplatin 7 day | N | null | 310018276 | CISPLATIN |
| 310007450 | 310007947 | 1.75 | null | Palliative (P) | null | 2014-10-07 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | null | 310018278 | CARBOPLATIN + ETOPOSIDE |
| 310007451 | 310007949 | 1.62 | 57.8 | Disease modification (D) | 2015-10-10 | 2015-10-12 | Etoposide IV | null | N | 310018282 | ETOPOSIDE |
| 310007455 | 310004593 | null | 80.1 | Curative (C) | 2017-11-20 | 2017-11-29 | Cyclophosphamide High Dose | N | N | 310018298 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007456 | 310004596 | 1.4 | 74.6 | Curative (C) | 2015-06-20 | 2015-06-20 | ESHAP | 02 | N | 310018316 | CARBOPLATIN + ETOPOSIDE |
| 310007457 | 310004598 | 1.89 | 91.7 | Palliative (P) | 2014-02-17 | 2014-02-19 | GDP | 02 | N | 310018317 | GDP |
| 310007458 | 310007953 | 1.72 | 70.8 | Palliative (P) | 2015-10-23 | 2016-03-10 | ETOPOSIDE | 02 | N | 310018323 | ETOPOSIDE |
| 310007459 | 310004602 | null | 83 | Curative (C) | 2014-12-21 | 2015-05-25 | Ipilimumab | N | null | 310018326 | IPILIMUMAB |
| 310007460 | 310004603 | 1.86 | 70.8 | Palliative (P) | 2016-09-05 | 2016-09-05 | Bexarotene | 02 | Y | 310018327 | BEXAROTENE |
| 310007461 | 310004603 | 1.73 | 86.8 | Curative (C) | 2013-05-09 | 2013-05-10 | Cisplatin | N | N | 310018327 | CISPLATIN |
| 310007462 | 310007955 | 1.73 | 74.4 | Curative (C) | 2017-08-26 | 2017-08-28 | Carboplatin + Etoposide iv&po | N | N | 310018339 | UKALL2011 |
| 310007463 | 310004605 | 1.68 | null | Curative (C) | 2014-01-01 | 2014-01-23 | GDP | N | null | 310018341 | GDP |
| 310007464 | 310004606 | 1.66 | 120 | Palliative (P) | 2016-02-03 | 2016-06-27 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | 310018342 | CYCLOPHOSPHAMIDE |
| 310007465 | 310007956 | 170 | 59.6 | Neo-adjuvant (N) | 2017-06-29 | 2017-07-30 | Docetaxel | 2 | N | 310018342 | DOCETAXEL |
| 310007466 | 310004607 | 1.54 | 66.1 | Curative (C) | 2014-12-22 | 2015-05-01 | Carboplatin + Etoposide iv&po | 02 | N | 310018351 | ESHAP |
| 310007467 | 310004608 | 1.63 | 65 | Adjuvant (A) | 2018-02-16 | 2019-03-05 | ESHAP | 99 | N | 310018356 | UKALL2011 |
| 310007468 | 310004609 | 1.81 | 71.1 | Adjuvant (A) | 2016-12-27 | 2017-01-18 | Etoposide oral | 02 | null | 310018360 | ETOPOSIDE |
| 310007469 | 310004610 | 1.8 | 73.499 | Curative (C) | 2016-04-08 | 2016-04-19 | Cyclophosphamide oral | N | null | 310018361 | CYCLOPHOSPHAMIDE |
| 310007472 | 310004614 | 1.63 | 57 | Curative (C) | 2017-04-06 | 2017-05-22 | Bexarotene | 02 | N | 310018369 | ESHAP |
| 310007473 | 310004615 | 1.82 | 92.5 | Disease modification (D) | 2018-05-02 | 2018-05-02 | Etoposide oral | 02 | null | 310018370 | ETOPOSIDE |
| 310007474 | 310004615 | 1.82 | 55.6 | Curative (C) | 2012-12-20 | 2017-03-23 | CHOP R - 21 days | 02 | N | 310018370 | CHOP R |
| 310007475 | 310004616 | 1.89 | null | Curative (C) | 2013-04-04 | 2013-05-22 | CYCLOPHOSPHAMIDE + MESNA | N | null | 310018386 | CYCLOPHOSPHAMIDE |
| 310007476 | 310004617 | null | 71 | Curative (C) | null | 2016-03-09 | Docetaxel | N | null | 310018387 | DOCETAXEL |
| 310007477 | 310004618 | 1.81 | null | Not known (9) | 2017-04-16 | 2017-06-03 | CARBOPLATIN + ETOPOSIDE | N | null | 310018389 | CARBOPLATIN + ETOPOSIDE |
| 310007478 | 310004619 | null | 66 | Palliative (P) | 2016-10-05 | 2016-10-05 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | null | 310018389 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007479 | 310004619 | null | null | Neo-adjuvant (N) | 2016-05-04 | 2016-05-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018389 | CARBOPLATIN + ETOPOSIDE |
| 310007480 | 310004619 | 1.7 | 74.7 | Adjuvant (A) | 2014-05-23 | 2014-06-24 | Etoposide oral | Y | N | 310018389 | ETOPOSIDE |